Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The 11th annual BIO-Europe Spring conference is just around the corner. The Pharma Intelligence team has several exciting activities lined up and we hope to see you there.
Spotlight panel discussion: Key considerations in microbiome partnering
Monday, 20 March 2017 16:00 - 17:00
Location: Level 1, Room 123
Moderator: Mike Ward, Global Content Director, Informa Pharma Insights
Panelists: Michel de Baar, Executive Director, BD&L, Infectious Diseases & Vaccines, Cardiovascular & Metabolic Diseases at MSD; Eric de la Fortelle, Venture Partner at Seventure; Mariona Serra-Pagès, CEO at Goodgut
The human microbiome is garnering research interest across the globe and industry is responding to the growing possibilities of therapeutic developments in a variety of ways, a key aspect of which is partnerships. The current state of play means emerging companies are often looking for specific expertise or experience in their partners, often influenced by the variety of approaches under different regulatory jurisdictions or financial structures. Join this panel to hear how emerging microbiome companies identify their preferred partners and what pharma companies and funders are able to bring to the table.
Hospitality Reception
Tuesday, 21 March, 17.45-18.45
Stand 51
Pharma Intelligence’s business development and licensing solutions provide the actionable intelligence you need to optimize your partnership strategy. Stop by our booth to learn more.
Interviews
Industry experts Lucie Ellis and Mike Ward will be available on Tuesday and Wednesday to conduct interviews. This year we are looking to hear from companies within the Biosimilars or MicroBiome development area as well as biotech starts ups.
To guarantee an interview please get in touch directly with Lucie or Mike.
In Vivo: strategic insights for life sciences decision-maker...
Pharma Intelligence offers a wealth of pharmaceutical industry news and strategic insight into the healthcare & biotechnology markets from around the world. Working in an interconnected global network, our 65 journalists and over 300 in-house analysts supply comprehensive analysis and reports.
Scrip: industry news and insights
The Swiss major's pharma chief tells Scrip that its gene therapy for SMA offers much more than Biogen's Spinraza for both patients and payers, noting that the company is ready with alternative payment models for the pricey treatment as soon as approvals for Zolgensma are granted.
Topics Business strategies Drug approval Drug development landscape Drug review
Scrip: industry news and insights
By Emily Hayes
In second Phase III diabetes study to report, oral GLP-1 agonist semaglutide misses some weight loss goals when compared with Boehringer/Lilly's SGLT-2 inhibitor Jardiance.
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Support the development and validation of your strategic plans and ensure commercial decisions are based on marketplace realities. Datamonitor Healthcare offers expert coverage of key diseases, treatments, companies, drugs, market access and market trends. Our primary research with physicians, payers, and KOLs (key opinion leaders) informs our treatment standards data and patient-based forecasts.
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
From discovery to patent expiry, and coverage spanning both ethical and generic drugs, Medtrack has you covered. Stay current on key financing, drug and biologics development and drug manufacturing information, all with a single tool.
Looking for more products Product Finder
